2006 | 2008 | 2009 | 2010
2010
HRT & CHD is there evidence for a window of opportunity?
Dr.Marco Gambacciono, EMAS lecture at EBCOG, Antwerp, May 2010
Should osteoporosis prevention start at the menopause or should we only target women at high risk?
Prof.Marc Brincat, Dr.J.Calleja-Agius, EMAS lecture at EBCOG, Antwerp, May 2010
Making sense of HT after menopause: is there a place for HT in view of the stroke risk?
Prof.Serge Rozenberg, EMAS lecture at EBCOG, Antwerp, May 2010
Is postmenopause hormone therapy acceptable in view of breast cancer risk?
Dr.Irene Lambrinoudaki, EMAS lecture at EBCOG, Antwerp, May 2010
Disclaimer:
The information contained on this page has been submitted by the Author. As such, the responsibility of content remains with the Author and is not an official statement from EMAS.
This material is to be used for educational purposes only and is not intended for commercial use. No information may be copied or cited without prior consent from the Author. The products mentioned are not necessarily endorsed by the Author.
For any further information, please contact the EMAS secretariat.